Sherwin-Williams (SHW) Financials

Sherwin-Williams logo
$343.86 -6.68 (-1.91%)
Closing price 03:59 PM Eastern
Extended Trading
$343.60 -0.26 (-0.08%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Sherwin-Williams

Annual Income Statements for Sherwin-Williams

This table shows Sherwin-Williams' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1,054 1,133 1,728 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Consolidated Net Income / (Loss)
1,054 1,133 1,728 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Net Income / (Loss) Continuing Operations
1,054 1,133 1,770 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Total Pre-Tax Income
1,549 1,595 1,469 1,360 1,982 2,519 2,249 2,573 3,110 3,452 3,338
Total Operating Income
1,646 1,745 1,712 2,067 2,326 2,861 2,559 3,003 3,568 3,812 3,813
Total Gross Profit
5,560 5,921 6,719 7,419 8,036 8,683 8,543 9,325 10,758 11,195 11,516
Total Revenue
11,339 11,856 14,984 17,535 17,901 18,362 19,945 22,149 23,052 23,099 23,574
Operating Revenue
11,339 11,856 14,984 17,535 17,901 18,362 19,945 22,149 23,052 23,099 23,574
Total Cost of Revenue
5,780 5,934 8,265 10,116 9,865 9,679 11,402 12,824 12,294 11,903 12,059
Operating Cost of Revenue
5,780 5,934 8,265 10,116 9,865 9,679 11,402 12,824 12,294 11,903 12,059
Total Operating Expenses
3,914 4,176 5,006 5,352 5,710 5,821 5,984 6,322 7,190 7,383 7,703
Selling, General & Admin Expense
3,886 4,140 4,798 5,034 5,275 5,478 5,882 6,332 7,065 7,422 7,695
Other Operating Expenses / (Income)
- - - - - 28 102 -25 67 -39 -10
Impairment Charge
0.00 11 2.00 0.00 122 2.30 0.00 16 58 0.00 18
Total Other Income / (Expense), net
-97 -150 -243 -707 -345 -342 -310 -430 -458 -360 -475
Interest Expense
62 154 264 367 349 340 335 391 418 416 465
Interest & Investment Income
1.40 4.96 8.60 5.20 26 3.60 4.90 8.00 25 11 11
Other Income / (Expense), net
-36 -0.55 12 -346 -21 -5.30 20 -47 -66 45 -21
Income Tax Expense
495 463 -300 251 441 489 384 553 721 770 770
Basic Earnings per Share
$11.43 $12.33 $18.60 $11.92 $5.60 $7.48 $7.10 $7.83 $9.35 $10.68 $10.37
Weighted Average Basic Shares Outstanding
92.20M 91.84M 92.90M 92.99M 275.40M 271.30M 262.50M 258M 255.40M 251M 247.60M
Diluted Earnings per Share
$11.15 $11.99 $18.20 $11.67 $5.50 $7.36 $6.98 $7.72 $9.25 $10.55 $10.26
Weighted Average Diluted Shares Outstanding
92.20M 91.84M 92.90M 94.99M 280.30M 275.80M 267.10M 261.80M 258.30M 254.10M 250.40M
Weighted Average Basic & Diluted Shares Outstanding
92.20M 91.84M 92.90M 93M 92.23M 89.60M 260.37M 258.44M 254.46M 251.36M 247.77M
Cash Dividends to Common per Share
$2.68 $3.36 $3.40 $3.44 $1.51 $1.79 $2.20 $2.40 $2.42 $2.86 $3.16

Quarterly Income Statements for Sherwin-Williams

This table shows Sherwin-Williams' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
505 890 806 480 504 755 833 477 535 844 821
Consolidated Net Income / (Loss)
505 890 806 480 504 755 833 477 535 844 821
Net Income / (Loss) Continuing Operations
505 890 806 480 504 755 833 477 535 844 821
Total Pre-Tax Income
640 1,173 1,023 616 653 986 1,061 639 680 1,113 1,064
Total Operating Income
729 1,251 1,133 698 756 1,100 1,177 779 805 1,231 1,203
Total Gross Profit
2,531 3,063 3,028 2,573 2,559 3,118 3,126 2,713 2,781 3,338 3,277
Total Revenue
5,367 6,272 6,163 5,297 5,306 6,315 6,358 5,596 5,667 6,789 6,860
Operating Revenue
5,367 6,272 6,163 5,297 5,306 6,315 6,358 5,596 5,667 6,789 6,860
Total Cost of Revenue
2,836 3,208 3,135 2,724 2,747 3,196 3,233 2,883 2,886 3,451 3,583
Operating Cost of Revenue
2,836 3,208 3,135 2,724 2,747 3,196 3,233 2,883 2,886 3,451 3,583
Total Operating Expenses
1,802 1,812 1,894 1,875 1,803 2,018 1,948 1,934 1,976 2,107 2,074
Selling, General & Admin Expense
1,800 1,846 1,894 1,883 1,794 2,012 1,953 1,937 1,970 2,104 2,069
Other Operating Expenses / (Income)
2.00 -34 0.70 -7.90 8.90 6.30 -4.70 -21 6.30 3.40 5.20
Total Other Income / (Expense), net
-89 -78 -110 -83 -103 -115 -117 -140 -125 -118 -139
Interest Expense
103 111 103 99 104 112 117 132 132 136 139
Interest & Investment Income
6.10 0.90 2.60 1.40 3.30 2.40 2.60 2.90 2.80 5.40 5.90
Other Income / (Expense), net
7.70 32 -9.50 15 -2.90 -4.70 -2.30 -11 4.00 12 -6.00
Income Tax Expense
135 284 217 136 149 231 227 162 145 269 243
Basic Earnings per Share
$2.00 $3.55 $3.22 $1.91 $2.02 $3.04 $3.38 $1.93 $2.18 $3.46 $3.41
Weighted Average Basic Shares Outstanding
252.50M 251M 250.60M 251M 249.40M 248.40M 246.20M 247.60M 245.70M 243.90M 240.70M
Diluted Earnings per Share
$1.97 $3.50 $3.18 $1.90 $2.00 $3.00 $3.35 $1.91 $2.15 $3.43 $3.38
Weighted Average Diluted Shares Outstanding
255.80M 254.20M 253.90M 254.10M 252.50M 251.30M 249M 250.40M 248.10M 246M 242.80M
Weighted Average Basic & Diluted Shares Outstanding
253.55M 252.26M 251.85M 251.36M 250.60M 249.33M 247.89M 247.77M 246.64M 242.76M 241.59M

Annual Cash Flow Statements for Sherwin-Williams

This table details how cash moves in and out of Sherwin-Williams' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
165 684 -649 -49 6.30 65 -61 33 78 -66 -3.20
Net Cash From Operating Activities
1,447 1,309 1,884 1,944 2,321 3,409 2,245 1,920 3,522 3,153 3,452
Net Cash From Continuing Operating Activities
1,447 1,309 1,884 1,944 2,321 3,409 2,245 1,920 3,522 3,153 3,452
Net Income / (Loss) Continuing Operations
1,054 1,133 1,770 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Consolidated Net Income / (Loss)
1,054 1,133 1,728 1,109 1,541 2,030 1,864 2,020 2,389 2,681 2,569
Depreciation Expense
170 172 285 278 262 268 263 264 292 297 340
Amortization Expense
31 89 329 330 322 405 363 356 396 402 441
Non-Cash Adjustments To Reconcile Net Income
176 168 235 348 758 490 568 587 591 514 708
Changes in Operating Assets and Liabilities, net
16 -253 -734 -122 -562 215 -814 -1,307 -146 -741 -605
Net Cash From Investing Activities
-289 -304 -9,047 -252 -463 -322 -476 -1,608 -1,039 -1,196 -2,066
Net Cash From Continuing Investing Activities
-289 -304 -9,047 -252 -463 -322 -476 -1,608 -1,039 -1,196 -2,066
Purchase of Property, Plant & Equipment
-234 -239 -223 -251 -329 -304 -372 -645 -888 -1,070 -798
Acquisitions
0.00 0.00 -8,810 0.00 -77 0.00 -211 -1,003 -265 -79 -1,211
Sale of Property, Plant & Equipment
11 38 47 38 6.90 61 15 33 70 12 11
Divestitures
- - - - 0.00 0.00 123 0.00 104 0.00 0.00
Other Investing Activities, net
-66 -103 -62 -39 -63 -79 -31 6.80 -60 -59 -68
Net Cash From Financing Activities
-980 -307 6,514 -1,747 -1,846 -3,020 -1,834 -282 -2,425 -2,017 -1,379
Net Cash From Continuing Financing Activities
-980 -307 6,514 -1,747 -1,846 -3,020 -1,834 -282 -2,425 -2,017 -1,379
Repayment of Debt
-673 -83 -1,942 -1,159 -2,134 -1,450 306 -77 -787 -890 -613
Repurchase of Common Equity
-1,035 0.00 0.00 -613 -779 -2,446 -2,752 -883 -1,432 -1,739 -1,656
Payment of Dividends
-250 -312 -319 -323 -421 -488 -587 -619 -624 -723 -790
Issuance of Debt
798 0.50 8,632 32 1,333 999 995 1,000 0.00 849 1,499
Other Financing Activities, net
180 87 144 316 155 183 193 275 418 486 181
Effect of Exchange Rate Changes
-13 -13 - 5.90 -6.00 -1.30 4.90 3.20 20 -6.20 -9.90
Cash Interest Paid
49 154 221 368 336 341 339 371 417 407 453
Cash Income Taxes Paid
335 478 420 292 408 437 466 580 817 780 593

Quarterly Cash Flow Statements for Sherwin-Williams

This table details how cash moves in and out of Sherwin-Williams' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-97 20 38 -28 -11 70 -28 -34 9.70 77 -29
Net Cash From Operating Activities
-59 1,203 1,075 935 -61 1,113 1,308 1,093 139 1,348 1,105
Net Cash From Continuing Operating Activities
-59 1,203 1,075 935 -61 1,113 1,308 1,093 139 1,348 1,105
Net Income / (Loss) Continuing Operations
505 890 806 480 504 755 833 477 535 844 821
Consolidated Net Income / (Loss)
505 890 806 480 504 755 833 477 535 844 821
Depreciation Expense
71 72 74 80 80 79 83 98 98 99 99
Amortization Expense
102 104 95 101 110 112 108 111 120 123 117
Non-Cash Adjustments To Reconcile Net Income
127 122 133 132 140 170 121 276 153 139 149
Changes in Operating Assets and Liabilities, net
-864 16 -34 142 -895 -3.50 163 130 -767 144 -81
Net Cash From Investing Activities
-321 -261 -329 -286 -316 -241 -1,337 -172 -171 -208 -152
Net Cash From Continuing Investing Activities
-321 -261 -329 -286 -316 -241 -1,337 -172 -171 -208 -152
Purchase of Property, Plant & Equipment
-284 -251 -235 -300 -189 -182 -196 -230 -138 -108 -129
Acquisitions
0.00 - - -79 -82 -39 2.10 -1,092 0.00 -65 -0.80
Other Investing Activities, net
-38 -19 -93 91 -45 -21 -1,143 1,140 -32 -40 -22
Net Cash From Financing Activities
290 -917 -719 -671 367 -810 6.50 -942 48 -1,064 -978
Net Cash From Continuing Financing Activities
290 -917 -719 -671 367 -810 6.50 -942 48 -1,064 -978
Repayment of Debt
-20 479 -1,089 -260 -283 -26 -837 534 -408 3.80 -527
Repurchase of Common Equity
-546 -434 -449 -310 -352 -519 -668 -118 -576 -1,261 -520
Payment of Dividends
-183 -179 -183 -180 -200 -198 -196 -196 -197 -198 -194
Issuance of Debt
883 - - - 1,136 -92 1,640 -1,184 1,181 373 220
Other Financing Activities, net
155 99 153 80 67 24 68 22 48 18 44
Effect of Exchange Rate Changes
-6.30 -4.60 11 -6.00 -0.50 8.50 -5.00 -13 -6.50 0.80 -4.10
Cash Interest Paid
108 106 109 85 120 100 124 110 160 116 158
Cash Income Taxes Paid
70 173 355 182 90 230 139 135 44 141 341

Annual Balance Sheets for Sherwin-Williams

This table presents Sherwin-Williams' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
5,779 6,753 19,900 19,134 20,496 20,402 20,667 22,594 22,954 23,633 25,902
Total Current Assets
2,657 3,627 4,407 4,345 4,632 4,591 5,054 5,908 5,513 5,401 6,007
Cash & Equivalents
206 890 204 156 162 227 166 199 277 210 207
Accounts Receivable
1,114 1,231 2,105 2,019 2,089 2,078 2,352 2,564 2,468 2,389 2,791
Inventories, net
1,019 1,068 1,743 1,815 1,890 1,804 1,927 2,627 2,330 2,288 2,318
Other Current Assets
231 381 356 355 491 483 608 519 438 514 691
Plant, Property, & Equipment, net
1,042 1,096 1,877 1,777 1,835 1,835 1,867 2,207 2,837 3,533 4,137
Total Noncurrent Assets
2,080 2,029 13,615 13,013 14,029 13,976 13,746 14,479 14,605 14,699 15,757
Goodwill
1,143 1,127 6,814 6,957 7,005 7,049 7,135 7,583 7,626 7,580 8,037
Intangible Assets
255 255 6,002 5,202 4,735 4,471 4,002 4,002 3,881 3,533 3,966
Other Noncurrent Operating Assets
436 422 502 584 2,290 2,455 2,610 2,894 3,098 3,585 3,754
Total Liabilities & Shareholders' Equity
5,779 6,753 19,900 19,134 20,496 20,402 20,667 22,594 22,954 23,633 25,902
Total Liabilities
4,911 4,874 16,252 15,404 16,373 16,791 18,230 19,492 19,239 19,581 21,303
Total Current Liabilities
2,142 2,829 3,987 4,298 4,522 4,594 5,720 5,961 6,627 6,809 6,920
Short-Term Debt
43 741 635 636 635 25 1,024 979 1,473 1,712 1,551
Accounts Payable
1,158 1,035 1,792 1,799 1,876 2,118 2,403 2,437 2,315 2,253 2,354
Current Deferred & Payable Income Tax Liabilities
81 77 80 81 86 184 160 197 197 174 187
Current Employee Benefit Liabilities
338 398 508 505 553 753 717 785 863 843 839
Other Current Liabilities
522 579 973 1,277 1,373 1,515 1,416 1,564 1,779 1,827 1,989
Total Noncurrent Liabilities
2,769 2,045 12,264 11,106 11,851 12,196 12,510 13,531 12,612 12,773 14,383
Long-Term Debt
1,907 1,211 9,886 8,708 8,051 8,267 8,591 9,591 8,378 8,177 9,321
Noncurrent Deferred & Payable Income Tax Liabilities
139 74 1,420 1,131 970 846 768 682 683 608 765
Noncurrent Employee Benefit Liabilities
249 250 275 258 263 276 259 139 133 121 130
Other Noncurrent Operating Liabilities
475 509 684 1,009 2,567 2,808 2,892 3,119 3,418 3,868 4,167
Total Equity & Noncontrolling Interests
868 1,878 3,648 3,731 4,123 3,611 2,437 3,102 3,716 4,051 4,598
Total Preferred & Common Equity
868 1,878 3,648 3,731 4,123 3,611 2,437 3,102 3,716 4,051 4,598
Total Common Equity
868 1,878 3,648 3,731 4,123 3,611 2,437 3,102 3,716 4,051 4,598
Common Stock
2,446 2,605 2,841 3,015 3,272 3,581 3,884 4,055 4,285 4,669 4,288
Retained Earnings
3,229 4,049 5,458 6,247 7,367 844 2,122 3,523 5,288 7,246 1,029
Treasury Stock
-4,220 -4,236 -4,266 -4,901 -5,837 -97 -2,870 -3,776 -5,234 -6,989 -84
Accumulated Other Comprehensive Income / (Loss)
-587 -540 -385 -630 -680 -718 -698 -701 -624 -875 -634

Quarterly Balance Sheets for Sherwin-Williams

This table presents Sherwin-Williams' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
22,954 23,428 23,734 23,968 23,633 24,636 25,364 26,206 26,379 26,951 26,961
Total Current Assets
5,513 5,842 6,051 5,974 5,401 6,040 6,425 6,146 6,500 6,999 7,027
Cash & Equivalents
277 180 200 238 210 200 270 242 217 294 264
Accounts Receivable
2,468 2,809 3,048 2,973 2,389 2,813 3,112 3,122 3,192 3,571 3,598
Inventories, net
2,330 2,378 2,289 2,267 2,288 2,515 2,485 2,276 2,473 2,530 2,547
Other Current Assets
438 475 513 495 514 512 559 506 618 605 618
Plant, Property, & Equipment, net
2,837 3,009 3,137 3,345 3,533 3,663 3,806 3,913 4,206 4,219 4,226
Total Noncurrent Assets
14,605 14,577 14,547 14,649 14,699 14,933 15,132 16,147 15,673 15,733 15,708
Goodwill
7,626 7,621 7,607 7,657 7,580 7,708 7,808 7,794 8,003 8,023 7,976
Intangible Assets
3,881 3,778 3,693 3,657 3,533 3,493 3,543 3,466 3,886 3,804 3,744
Other Noncurrent Operating Assets
3,098 3,178 3,247 3,335 3,585 3,731 3,781 4,887 3,784 3,906 3,989
Total Liabilities & Shareholders' Equity
22,954 23,428 23,734 23,968 23,633 24,636 25,364 26,206 26,379 26,951 26,961
Total Liabilities
19,239 19,924 19,982 19,812 19,581 20,506 20,963 21,781 21,948 23,097 22,985
Total Current Liabilities
6,627 7,484 7,467 7,218 6,809 7,877 8,196 7,474 7,535 9,627 9,849
Short-Term Debt
1,473 2,605 2,208 1,964 1,712 2,949 2,857 2,197 2,377 3,745 3,852
Accounts Payable
2,315 2,454 2,494 2,538 2,253 2,513 2,570 2,442 2,603 2,826 2,895
Current Deferred & Payable Income Tax Liabilities
197 240 347 215 174 226 256 255 272 405 300
Current Employee Benefit Liabilities
863 560 709 726 843 567 689 709 592 768 817
Other Current Liabilities
1,779 1,624 1,709 1,776 1,827 1,622 1,824 1,871 1,691 1,882 1,983
Total Noncurrent Liabilities
12,612 12,441 12,516 12,594 12,773 12,629 12,766 14,308 14,413 13,470 13,136
Long-Term Debt
8,378 8,130 8,131 8,175 8,177 7,827 7,829 9,318 9,323 8,327 7,943
Noncurrent Deferred & Payable Income Tax Liabilities
683 666 642 632 608 586 561 657 765 757 742
Noncurrent Employee Benefit Liabilities
133 133 133 133 121 121 121 121 132 133 134
Other Noncurrent Operating Liabilities
3,418 3,512 3,610 3,654 3,868 4,096 4,256 4,212 4,193 4,252 4,317
Total Equity & Noncontrolling Interests
3,716 3,504 3,752 4,156 4,051 4,130 4,401 4,425 4,431 3,855 3,977
Total Preferred & Common Equity
3,716 3,504 3,752 4,156 4,051 4,130 4,401 4,425 4,431 3,855 3,977
Total Common Equity
3,716 3,504 3,752 4,156 4,051 4,130 4,401 4,425 4,431 3,855 3,977
Common Stock
4,285 4,391 4,434 4,564 4,669 4,715 4,773 4,821 4,359 4,405 4,443
Retained Earnings
5,288 5,611 6,322 6,946 7,246 7,550 8,107 8,744 1,367 2,013 2,640
Treasury Stock
-5,234 -5,793 -6,228 -6,678 -6,989 -7,362 -7,881 -8,549 -708 -1,970 -2,490
Accumulated Other Comprehensive Income / (Loss)
-624 -705 -777 -676 -875 -773 -598 -590 -587 -594 -616

Annual Metrics And Ratios for Sherwin-Williams

This table displays calculated financial ratios and metrics derived from Sherwin-Williams' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.88% 4.55% 26.39% 17.02% 2.09% 2.57% 8.62% 11.05% 4.08% 0.20% 2.06%
EBITDA Growth
19.02% 10.74% 16.58% -0.36% 24.03% 22.15% -9.20% 11.57% 17.19% 8.72% 0.38%
EBIT Growth
21.97% 8.39% -1.16% -0.17% 33.93% 23.89% -9.72% 14.64% 18.48% 10.12% -1.67%
NOPAT Growth
21.28% 10.66% 66.45% -18.28% 7.36% 27.46% -8.00% 11.12% 16.24% 8.05% -0.92%
Net Income Growth
21.71% 7.48% 52.55% -35.84% 39.02% 31.73% -8.18% 8.35% 18.25% 12.25% -4.21%
EPS Growth
27.14% 7.53% 51.79% -35.88% 39.02% 31.73% -5.16% 10.60% 19.82% 14.05% -2.75%
Operating Cash Flow Growth
33.84% -9.60% 43.97% 3.17% 19.43% 46.84% -34.15% -14.47% 83.44% -10.47% 9.46%
Free Cash Flow Firm Growth
37.14% -27.91% -1,084.87% 130.47% -23.77% 57.42% -41.66% -59.66% 279.17% -13.74% -44.46%
Invested Capital Growth
-5.17% 12.60% 374.78% -7.49% -2.11% -7.67% 1.80% 13.35% -1.36% 3.31% 11.17%
Revenue Q/Q Growth
0.31% 1.52% 8.68% 0.49% 0.28% 2.08% 1.39% 2.16% 0.09% 0.20% 1.28%
EBITDA Q/Q Growth
6.54% 2.33% 5.05% -7.51% 6.13% 9.80% -6.98% 5.18% -0.87% 4.00% 1.86%
EBIT Q/Q Growth
7.55% 1.70% -1.81% -6.76% 7.86% 8.71% -7.03% 7.62% -1.15% 4.15% 1.47%
NOPAT Q/Q Growth
5.43% -0.28% 66.31% -33.66% -1.42% 7.34% -7.36% 8.92% 0.68% 2.06% 1.31%
Net Income Q/Q Growth
6.60% 0.44% 60.30% -40.42% 10.60% 8.46% -5.24% 4.25% -1.24% 4.84% -0.13%
EPS Q/Q Growth
7.31% 0.59% 59.79% -41.62% 10.60% 8.46% -7.18% 2.66% -2.43% 5.08% 0.10%
Operating Cash Flow Q/Q Growth
31.26% -13.43% 17.69% -5.48% 6.78% 5.74% -22.48% 30.36% 8.56% 0.51% 4.80%
Free Cash Flow Firm Q/Q Growth
26.09% -25.29% 4.52% 4.94% -17.21% 8.80% -32.11% 49.44% 16.41% 22.63% 11.68%
Invested Capital Q/Q Growth
-7.77% 2.95% 3.57% -3.74% -0.74% -1.70% 4.70% 3.62% 0.59% -2.34% -2.78%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
49.03% 49.94% 44.84% 42.31% 44.89% 47.29% 42.83% 42.10% 46.67% 48.47% 48.85%
EBITDA Margin
15.97% 16.92% 15.60% 13.29% 16.14% 19.22% 16.07% 16.14% 18.18% 19.72% 19.40%
Operating Margin
14.51% 14.72% 11.43% 11.79% 13.00% 15.58% 12.83% 13.56% 15.48% 16.50% 16.17%
EBIT Margin
14.19% 14.71% 11.51% 9.82% 12.88% 15.55% 12.93% 13.35% 15.19% 16.70% 16.09%
Profit (Net Income) Margin
9.29% 9.55% 11.53% 6.32% 8.61% 11.06% 9.35% 9.12% 10.36% 11.61% 10.90%
Tax Burden Percent
68.04% 71.01% 117.60% 81.54% 77.77% 80.60% 82.91% 78.51% 76.81% 77.68% 76.94%
Interest Burden Percent
96.25% 91.45% 85.22% 79.00% 85.97% 88.21% 87.21% 87.05% 88.80% 89.51% 88.03%
Effective Tax Rate
31.96% 28.99% -20.43% 18.46% 22.23% 19.40% 17.09% 21.49% 23.19% 22.32% 23.06%
Return on Invested Capital (ROIC)
41.73% 44.62% 24.40% 12.54% 14.15% 18.96% 18.01% 18.59% 20.48% 21.92% 20.24%
ROIC Less NNEP Spread (ROIC-NNEP)
37.97% 37.05% 18.52% 6.63% 11.13% 15.64% 15.07% 15.19% 16.95% 19.01% 16.65%
Return on Net Nonoperating Assets (RNNOA)
71.32% 37.87% 38.14% 17.51% 25.10% 33.54% 43.64% 54.34% 49.59% 47.13% 39.15%
Return on Equity (ROE)
113.05% 82.49% 62.53% 30.05% 39.25% 52.51% 61.65% 72.94% 70.07% 69.05% 59.39%
Cash Return on Invested Capital (CROIC)
47.03% 32.77% -106.01% 20.31% 16.28% 26.94% 16.22% 6.08% 21.85% 18.67% 9.66%
Operating Return on Assets (OROA)
28.04% 27.84% 12.94% 8.82% 11.63% 13.97% 12.56% 13.67% 15.38% 16.56% 15.31%
Return on Assets (ROA)
18.36% 18.08% 12.97% 5.68% 7.78% 9.93% 9.08% 9.34% 10.49% 11.51% 10.37%
Return on Common Equity (ROCE)
113.05% 82.49% 62.53% 30.05% 39.25% 52.51% 61.65% 72.94% 70.07% 69.05% 59.39%
Return on Equity Simple (ROE_SIMPLE)
121.42% 60.30% 47.37% 29.72% 37.38% 56.23% 76.50% 65.12% 64.29% 66.19% 0.00%
Net Operating Profit after Tax (NOPAT)
1,120 1,239 2,062 1,685 1,809 2,306 2,122 2,358 2,740 2,961 2,934
NOPAT Margin
9.87% 10.45% 13.76% 9.61% 10.11% 12.56% 10.64% 10.64% 11.89% 12.82% 12.44%
Net Nonoperating Expense Percent (NNEP)
3.76% 7.57% 5.88% 5.91% 3.03% 3.32% 2.94% 3.40% 3.53% 2.91% 3.59%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 17.24% 20.20% 21.24% 18.96%
Cost of Revenue to Revenue
50.97% 50.06% 55.16% 57.69% 55.11% 52.71% 57.17% 57.90% 53.33% 51.53% 51.15%
SG&A Expenses to Revenue
34.27% 34.92% 32.02% 28.71% 29.47% 29.83% 29.49% 28.59% 30.65% 32.13% 32.64%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
34.52% 35.23% 33.41% 30.52% 31.90% 31.70% 30.00% 28.54% 31.19% 31.96% 32.67%
Earnings before Interest and Taxes (EBIT)
1,609 1,744 1,724 1,721 2,305 2,856 2,578 2,956 3,502 3,857 3,792
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,811 2,006 2,338 2,330 2,889 3,529 3,205 3,576 4,190 4,556 4,573
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
25.64 12.39 9.90 9.38 12.52 17.87 36.92 19.47 21.31 21.13 17.47
Price to Tangible Book Value (P/TBV)
0.00 46.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.96 1.96 2.41 1.99 2.88 3.51 4.51 2.73 3.43 3.71 3.41
Price to Earnings (P/E)
21.12 20.55 20.89 31.55 33.49 31.78 48.26 29.90 33.14 31.93 31.27
Dividend Yield
1.12% 1.34% 0.88% 0.92% 0.81% 0.75% 0.64% 1.03% 0.78% 0.84% 0.98%
Earnings Yield
4.74% 4.87% 4.79% 3.17% 2.99% 3.15% 2.07% 3.35% 3.02% 3.13% 3.20%
Enterprise Value to Invested Capital (EV/IC)
9.19 8.27 3.32 3.42 4.76 6.22 8.36 5.25 6.68 6.94 5.96
Enterprise Value to Revenue (EV/Rev)
2.12 2.05 3.10 2.52 3.36 3.95 4.99 3.19 3.85 4.13 3.86
Enterprise Value to EBITDA (EV/EBITDA)
13.25 12.13 19.85 18.96 20.82 20.57 31.03 19.79 21.18 20.92 19.90
Enterprise Value to EBIT (EV/EBIT)
14.91 13.95 26.92 25.66 26.09 25.42 38.56 23.94 25.34 24.71 24.00
Enterprise Value to NOPAT (EV/NOPAT)
21.43 19.64 22.51 26.21 33.24 31.48 46.86 30.02 32.38 32.18 31.01
Enterprise Value to Operating Cash Flow (EV/OCF)
16.58 18.60 24.64 22.72 25.91 21.30 44.29 36.86 25.20 30.22 26.36
Enterprise Value to Free Cash Flow (EV/FCFF)
19.02 26.75 0.00 16.17 28.90 22.16 52.01 91.78 30.36 37.79 64.97
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.25 1.04 2.88 2.50 2.11 2.30 3.95 3.41 2.65 2.44 2.36
Long-Term Debt to Equity
2.20 0.64 2.71 2.33 1.95 2.29 3.52 3.09 2.25 2.02 2.03
Financial Leverage
1.88 1.02 2.06 2.64 2.26 2.14 2.90 3.58 2.93 2.48 2.35
Leverage Ratio
6.16 4.56 4.82 5.29 5.05 5.29 6.79 7.81 6.68 6.00 5.73
Compound Leverage Factor
5.93 4.17 4.11 4.18 4.34 4.66 5.92 6.80 5.93 5.37 5.04
Debt to Total Capital
69.20% 50.97% 74.25% 71.47% 67.81% 69.66% 79.78% 77.31% 72.61% 70.94% 70.28%
Short-Term Debt to Total Capital
1.51% 19.35% 4.48% 4.86% 4.95% 0.21% 8.50% 7.16% 10.86% 12.28% 10.02%
Long-Term Debt to Total Capital
67.69% 31.62% 69.77% 66.60% 62.85% 69.45% 71.28% 70.15% 61.75% 58.66% 60.25%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
30.80% 49.03% 25.75% 28.53% 32.19% 30.34% 20.22% 22.69% 27.39% 29.06% 29.72%
Debt to EBITDA
1.08 0.97 4.50 4.01 3.01 2.35 3.00 2.96 2.35 2.17 2.38
Net Debt to EBITDA
0.96 0.53 4.41 3.94 2.95 2.29 2.95 2.90 2.28 2.12 2.33
Long-Term Debt to EBITDA
1.05 0.60 4.23 3.74 2.79 2.34 2.68 2.68 2.00 1.79 2.04
Debt to NOPAT
1.74 1.58 5.10 5.54 4.80 3.60 4.53 4.48 3.59 3.34 3.71
Net Debt to NOPAT
1.56 0.86 5.00 5.45 4.71 3.50 4.45 4.40 3.49 3.27 3.64
Long-Term Debt to NOPAT
1.70 0.98 4.79 5.17 4.45 3.58 4.05 4.07 3.06 2.76 3.18
Altman Z-Score
6.49 6.45 2.78 3.04 3.65 3.73 4.44 3.49 4.24 4.50 3.67
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.24 1.28 1.11 1.01 1.02 1.00 0.88 0.99 0.83 0.79 0.87
Quick Ratio
0.62 0.75 0.58 0.51 0.50 0.50 0.44 0.46 0.41 0.38 0.43
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,262 910 -8,961 2,731 2,081 3,277 1,911 771 2,924 2,522 1,401
Operating Cash Flow to CapEx
648.97% 652.36% 1,072.89% 914.25% 720.90% 1,402.14% 628.39% 314.07% 430.39% 297.92% 438.63%
Free Cash Flow to Firm to Interest Expense
20.42 5.90 -34.01 7.45 5.96 9.63 5.71 1.97 7.00 6.07 3.01
Operating Cash Flow to Interest Expense
23.43 8.49 7.15 5.30 6.65 10.01 6.71 4.91 8.44 7.59 7.42
Operating Cash Flow Less CapEx to Interest Expense
19.82 7.19 6.48 4.72 5.72 9.30 5.64 3.35 6.48 5.04 5.73
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.98 1.89 1.12 0.90 0.90 0.90 0.97 1.02 1.01 0.99 0.95
Accounts Receivable Turnover
10.10 10.11 8.98 8.50 8.72 8.81 9.00 9.01 9.16 9.51 9.10
Inventory Turnover
5.63 5.69 5.88 5.69 5.33 5.24 6.11 5.63 4.96 5.16 5.24
Fixed Asset Turnover
10.99 11.09 10.08 9.60 9.91 10.01 10.78 10.87 9.14 7.25 6.15
Accounts Payable Turnover
5.25 5.41 5.85 5.63 5.37 4.85 5.04 5.30 5.17 5.21 5.23
Days Sales Outstanding (DSO)
36.13 36.10 40.63 42.92 41.88 41.42 40.54 40.51 39.83 38.37 40.10
Days Inventory Outstanding (DIO)
64.80 64.18 62.07 64.19 68.54 69.64 59.72 64.81 73.58 70.80 69.71
Days Payable Outstanding (DPO)
69.46 67.42 62.40 64.78 68.00 75.31 72.36 68.87 70.54 70.04 69.73
Cash Conversion Cycle (CCC)
31.47 32.86 40.29 42.32 42.42 35.75 27.90 36.44 42.87 39.13 40.08
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,612 2,941 13,964 12,919 12,647 11,676 11,887 13,473 13,290 13,729 15,262
Invested Capital Turnover
4.23 4.27 1.77 1.30 1.40 1.51 1.69 1.75 1.72 1.71 1.63
Increase / (Decrease) in Invested Capital
-142 329 11,023 -1,045 -272 -970 210 1,587 -183 439 1,533
Enterprise Value (EV)
23,998 24,334 46,415 44,163 60,144 72,595 99,423 70,762 88,746 95,290 90,989
Market Capitalization
22,254 23,272 36,099 34,975 51,620 64,530 89,974 60,392 79,172 85,612 80,325
Book Value per Share
$9.32 $20.22 $39.01 $39.85 $44.67 $39.76 $9.30 $11.97 $14.52 $16.09 $18.55
Tangible Book Value per Share
($5.70) $5.34 ($98.05) ($90.01) ($82.51) ($87.09) ($33.18) ($32.74) ($30.44) ($28.04) ($29.87)
Total Capital
2,818 3,831 14,169 13,074 12,809 11,903 12,052 13,672 13,567 13,940 15,470
Total Debt
1,950 1,953 10,521 9,344 8,685 8,292 9,615 10,570 9,851 9,888 10,871
Total Long-Term Debt
1,907 1,211 9,886 8,708 8,051 8,267 8,591 9,591 8,378 8,177 9,321
Net Debt
1,744 1,063 10,316 9,188 8,523 8,066 9,449 10,371 9,574 9,678 10,664
Capital Expenditures (CapEx)
223 201 176 213 322 243 357 611 818 1,058 787
Debt-free, Cash-free Net Working Capital (DFCFNWC)
352 650 851 527 583 -204 193 727 82 93 431
Debt-free Net Working Capital (DFNWC)
558 1,539 1,055 682 744 22 358 926 359 304 638
Net Working Capital (NWC)
515 798 420 47 110 -3.00 -666 -53 -1,114 -1,408 -913
Net Nonoperating Expense (NNE)
66 106 334 576 268 276 257 337 352 280 365
Net Nonoperating Obligations (NNO)
1,744 1,063 10,316 9,188 8,523 8,066 9,449 10,371 9,574 9,678 10,664
Total Depreciation and Amortization (D&A)
202 261 614 608 584 673 626 620 688 699 781
Debt-free, Cash-free Net Working Capital to Revenue
3.11% 5.48% 5.68% 3.00% 3.25% -1.11% 0.97% 3.28% 0.36% 0.40% 1.83%
Debt-free Net Working Capital to Revenue
4.92% 12.98% 7.04% 3.89% 4.16% 0.12% 1.80% 4.18% 1.56% 1.31% 2.71%
Net Working Capital to Revenue
4.54% 6.73% 2.80% 0.27% 0.61% -0.02% -3.34% -0.24% -4.83% -6.10% -3.87%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.79 $4.11 $6.36 $3.97 $5.60 $7.48 $7.10 $7.83 $9.35 $10.68 $10.37
Adjusted Weighted Average Basic Shares Outstanding
276.81M 279.92M 281.98M 278.15M 276.68M 271.28M 262.50M 258M 255.40M 251M 247.60M
Adjusted Diluted Earnings per Share
$3.72 $4.00 $6.22 $3.89 $5.50 $7.36 $6.98 $7.72 $9.25 $10.55 $10.26
Adjusted Weighted Average Diluted Shares Outstanding
276.81M 279.92M 281.98M 278.15M 276.68M 275.83M 267.10M 261.80M 258.30M 254.10M 250.40M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
276.81M 279.92M 281.98M 278.15M 276.68M 268.81M 260.37M 258.44M 254.46M 251.36M 247.77M
Normalized Net Operating Profit after Tax (NOPAT)
1,120 1,247 1,200 1,685 1,904 2,308 2,122 2,370 2,785 2,961 2,947
Normalized NOPAT Margin
9.87% 10.51% 8.01% 9.61% 10.64% 12.57% 10.64% 10.70% 12.08% 12.82% 12.50%
Pre Tax Income Margin
13.66% 13.46% 9.81% 7.75% 11.07% 13.72% 11.27% 11.62% 13.49% 14.94% 14.16%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
26.05 11.32 6.54 4.69 6.60 8.39 7.70 7.56 8.39 9.28 8.15
NOPAT to Interest Expense
18.12 8.04 7.83 4.60 5.18 6.77 6.34 6.03 6.56 7.12 6.31
EBIT Less CapEx to Interest Expense
22.44 10.02 5.88 4.11 5.68 7.68 6.64 6.00 6.43 6.73 6.46
NOPAT Less CapEx to Interest Expense
14.51 6.74 7.16 4.02 4.26 6.06 5.27 4.47 4.60 4.58 4.62
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
23.69% 27.55% 18.46% 29.12% 27.30% 24.03% 31.49% 30.62% 26.11% 26.98% 30.75%
Augmented Payout Ratio
121.93% 27.55% 18.46% 84.44% 77.83% 144.52% 179.11% 74.34% 86.06% 91.83% 95.24%

Quarterly Metrics And Ratios for Sherwin-Williams

This table displays calculated financial ratios and metrics derived from Sherwin-Williams' official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 246,635,621.00 242,758,151.00 241,588,072.00
DEI Adjusted Shares Outstanding
- - - - - - - - 246,635,621.00 242,758,151.00 241,588,072.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 2.17 3.48 3.40
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.38% 0.50% 0.75% 0.86% -1.15% 0.69% 3.18% 5.64% 6.81% 7.52% 7.89%
EBITDA Growth
1.80% 12.60% 0.86% 24.35% 3.61% -11.78% 5.62% 9.36% 8.88% 13.75% 3.47%
EBIT Growth
2.26% 14.93% 1.61% 27.45% 2.25% -14.62% 4.58% 7.72% 7.31% 13.44% 1.86%
NOPAT Growth
3.33% 8.94% 7.80% 12.92% 1.40% -11.22% 3.56% 6.71% 8.42% 10.78% 0.40%
Net Income Growth
5.82% 12.12% 5.87% 34.78% -0.26% -15.19% 3.34% -0.69% 6.11% 11.78% -1.45%
EPS Growth
7.07% 14.01% 7.80% 36.69% 1.52% -14.29% 5.35% 0.53% 7.50% 14.33% 0.90%
Operating Cash Flow Growth
-166.78% -0.29% -17.88% 1.73% -3.74% -7.51% 21.67% 16.91% 327.66% 21.11% -15.53%
Free Cash Flow Firm Growth
154.84% 303.20% -92.21% -84.19% -110.59% -109.56% -1,588.87% -1,004.93% -793.24% 239.39% 256.30%
Invested Capital Growth
-0.23% 0.49% 6.40% 3.31% 4.61% 6.67% 11.68% 11.17% 8.21% 5.51% -1.22%
Revenue Q/Q Growth
2.19% 16.85% -1.74% -14.04% 0.16% 19.01% 0.69% -11.99% 1.27% 19.81% 1.04%
EBITDA Q/Q Growth
26.66% 60.28% -11.39% -30.88% 5.54% 36.48% 6.09% -28.44% 5.08% 42.59% -3.50%
EBIT Q/Q Growth
31.78% 74.15% -12.44% -36.57% 5.72% 45.41% 7.25% -34.67% 5.33% 53.72% -3.71%
NOPAT Q/Q Growth
19.37% 64.86% -5.88% -39.03% 7.19% 44.34% 9.78% -37.18% 8.92% 47.49% -0.51%
Net Income Q/Q Growth
41.83% 76.15% -9.41% -40.45% 4.96% 49.77% 10.39% -42.77% 12.14% 57.77% -2.68%
EPS Q/Q Growth
41.73% 77.67% -9.14% -40.25% 5.26% 50.00% 11.67% -42.99% 12.57% 59.53% -1.46%
Operating Cash Flow Q/Q Growth
-106.41% 2,142.28% -10.66% -13.05% -106.54% 1,920.95% 17.53% -16.45% -87.27% 868.73% -18.03%
Free Cash Flow Firm Q/Q Growth
-8.72% 45.14% -94.54% 118.56% -161.12% -31.05% -750.46% -32.84% 39.67% 120.45% 853.61%
Invested Capital Q/Q Growth
5.78% -1.20% 1.20% -2.34% 7.12% 0.75% 5.95% -2.78% 4.27% -1.76% -0.80%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.16% 48.85% 49.13% 48.58% 48.23% 49.38% 49.16% 48.47% 49.07% 49.17% 47.77%
EBITDA Margin
16.96% 23.26% 20.98% 16.87% 17.78% 20.38% 21.48% 17.46% 18.12% 21.56% 20.60%
Operating Margin
13.59% 19.95% 18.39% 13.18% 14.26% 17.43% 18.52% 13.92% 14.20% 18.13% 17.54%
EBIT Margin
13.73% 20.46% 18.23% 13.45% 14.20% 17.35% 18.48% 13.72% 14.27% 18.31% 17.45%
Profit (Net Income) Margin
9.41% 14.19% 13.08% 9.06% 9.50% 11.95% 13.10% 8.52% 9.44% 12.43% 11.97%
Tax Burden Percent
78.94% 75.84% 78.82% 77.99% 77.17% 76.56% 78.56% 74.62% 78.66% 75.83% 77.20%
Interest Burden Percent
86.85% 91.44% 91.03% 86.38% 86.66% 89.96% 90.25% 83.24% 84.07% 89.50% 88.85%
Effective Tax Rate
21.06% 24.16% 21.18% 22.01% 22.83% 23.44% 21.44% 25.38% 21.34% 24.17% 22.80%
Return on Invested Capital (ROIC)
17.51% 25.12% 24.50% 17.58% 17.62% 21.45% 22.76% 16.89% 17.46% 22.04% 21.61%
ROIC Less NNEP Spread (ROIC-NNEP)
16.85% 24.54% 23.60% 16.91% 16.87% 20.60% 21.89% 15.86% 16.57% 21.23% 20.67%
Return on Net Nonoperating Assets (RNNOA)
54.26% 67.59% 57.51% 41.91% 46.69% 51.94% 54.02% 37.30% 42.69% 57.08% 56.10%
Return on Equity (ROE)
71.77% 92.71% 82.01% 59.48% 64.31% 73.39% 76.77% 54.19% 60.15% 79.12% 77.71%
Cash Return on Invested Capital (CROIC)
19.83% 19.98% 15.08% 18.67% 16.14% 13.50% 8.43% 9.66% 11.59% 14.82% 20.94%
Operating Return on Assets (OROA)
13.55% 20.08% 17.90% 13.34% 13.61% 16.31% 17.15% 13.06% 13.39% 17.09% 16.35%
Return on Assets (ROA)
9.29% 13.92% 12.84% 8.99% 9.10% 11.24% 12.16% 8.11% 8.85% 11.60% 11.22%
Return on Common Equity (ROCE)
71.77% 92.71% 82.01% 59.48% 64.31% 73.39% 76.77% 54.19% 60.15% 79.12% 77.71%
Return on Equity Simple (ROE_SIMPLE)
68.97% 66.98% 61.54% 0.00% 64.89% 57.83% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
576 949 893 545 584 843 925 581 633 933 929
NOPAT Margin
10.72% 15.13% 14.49% 10.28% 11.00% 13.34% 14.55% 10.38% 11.17% 13.75% 13.54%
Net Nonoperating Expense Percent (NNEP)
0.66% 0.58% 0.90% 0.67% 0.76% 0.85% 0.87% 1.02% 0.89% 0.81% 0.94%
Return On Investment Capital (ROIC_SIMPLE)
- - - 3.91% 3.92% 5.58% 5.80% 3.76% 3.92% 5.86% 5.89%
Cost of Revenue to Revenue
52.84% 51.15% 50.87% 51.42% 51.77% 50.62% 50.84% 51.53% 50.93% 50.83% 52.23%
SG&A Expenses to Revenue
33.53% 29.43% 30.73% 35.55% 33.81% 31.86% 30.71% 34.61% 34.76% 30.99% 30.16%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
33.57% 28.89% 30.74% 35.40% 33.98% 31.96% 30.64% 34.56% 34.87% 31.04% 30.24%
Earnings before Interest and Taxes (EBIT)
737 1,283 1,124 713 754 1,096 1,175 768 809 1,243 1,197
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
910 1,459 1,293 894 943 1,287 1,366 977 1,027 1,464 1,413
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
25.27 20.13 23.17 21.13 21.25 19.55 19.51 17.47 17.92 22.03 19.73
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
3.85 3.28 4.18 3.71 3.81 3.73 3.71 3.41 3.32 3.48 3.15
Price to Earnings (P/E)
36.63 30.05 37.65 31.93 32.75 33.81 33.57 31.27 30.56 31.59 29.32
Dividend Yield
0.73% 0.89% 0.72% 0.84% 0.84% 0.88% 0.89% 0.98% 0.99% 0.92% 0.99%
Earnings Yield
2.73% 3.33% 2.66% 3.13% 3.05% 2.96% 2.98% 3.20% 3.27% 3.17% 3.41%
Enterprise Value to Invested Capital (EV/IC)
7.05 6.17 7.55 6.94 6.69 6.51 6.22 5.96 5.71 6.19 5.80
Enterprise Value to Revenue (EV/Rev)
4.31 3.72 4.61 4.13 4.27 4.18 4.19 3.86 3.80 3.96 3.61
Enterprise Value to EBITDA (EV/EBITDA)
23.56 19.60 24.24 20.92 21.43 21.84 21.74 19.90 19.52 20.01 18.44
Enterprise Value to EBIT (EV/EBIT)
28.16 23.24 28.67 24.71 25.39 26.17 26.12 24.00 23.63 24.21 22.41
Enterprise Value to NOPAT (EV/NOPAT)
35.91 30.21 36.60 32.18 33.12 33.68 33.71 31.01 30.48 31.47 29.26
Enterprise Value to Operating Cash Flow (EV/OCF)
29.36 25.41 33.84 30.22 31.21 31.52 29.64 26.36 24.89 24.88 24.43
Enterprise Value to Free Cash Flow (EV/FCFF)
35.50 30.94 51.63 37.79 42.36 49.79 77.83 64.97 51.21 42.84 27.54
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
3.06 2.76 2.44 2.44 2.61 2.43 2.60 2.36 2.64 3.13 2.97
Long-Term Debt to Equity
2.32 2.17 1.97 2.02 1.90 1.78 2.11 2.03 2.10 2.16 2.00
Financial Leverage
3.22 2.75 2.44 2.48 2.77 2.52 2.47 2.35 2.58 2.69 2.71
Leverage Ratio
6.98 6.35 5.92 6.00 6.30 6.02 5.85 5.73 5.96 6.34 6.33
Compound Leverage Factor
6.06 5.81 5.39 5.18 5.46 5.42 5.28 4.77 5.01 5.67 5.62
Debt to Total Capital
75.39% 73.37% 70.93% 70.94% 72.29% 70.83% 72.24% 70.28% 72.53% 75.80% 74.79%
Short-Term Debt to Total Capital
18.30% 15.67% 13.74% 12.28% 19.79% 18.94% 13.78% 10.02% 14.73% 23.51% 24.43%
Long-Term Debt to Total Capital
57.09% 57.70% 57.19% 58.66% 52.51% 51.89% 58.45% 60.25% 57.80% 52.28% 50.36%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
24.61% 26.63% 29.07% 29.06% 27.71% 29.17% 27.76% 29.72% 27.47% 24.20% 25.21%
Debt to EBITDA
2.55 2.37 2.31 2.17 2.35 2.42 2.57 2.38 2.51 2.50 2.42
Net Debt to EBITDA
2.51 2.32 2.26 2.12 2.31 2.36 2.51 2.33 2.47 2.44 2.36
Long-Term Debt to EBITDA
1.93 1.86 1.87 1.79 1.71 1.77 2.08 2.04 2.00 1.72 1.63
Debt to NOPAT
3.89 3.65 3.49 3.34 3.63 3.73 3.98 3.71 3.92 3.93 3.83
Net Debt to NOPAT
3.83 3.58 3.41 3.27 3.56 3.64 3.89 3.64 3.85 3.83 3.75
Long-Term Debt to NOPAT
2.95 2.87 2.82 2.76 2.64 2.73 3.22 3.18 3.13 2.71 2.58
Altman Z-Score
4.00 3.72 4.38 4.06 3.94 3.88 3.82 3.28 3.21 3.25 3.13
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.78 0.81 0.83 0.79 0.77 0.78 0.82 0.87 0.86 0.73 0.71
Quick Ratio
0.40 0.44 0.44 0.38 0.38 0.41 0.45 0.43 0.45 0.40 0.39
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
607 881 48 105 -64 -84 -717 -952 -574 117 1,120
Operating Cash Flow to CapEx
-20.75% 479.43% 456.74% 313.91% -32.28% 613.00% 665.78% 497.27% 100.58% 1,243.08% 858.20%
Free Cash Flow to Firm to Interest Expense
5.90 7.96 0.47 1.07 -0.62 -0.75 -6.12 -7.24 -4.37 0.86 8.04
Operating Cash Flow to Interest Expense
-0.57 10.86 10.39 9.49 -0.59 9.90 11.16 8.30 1.06 9.92 7.93
Operating Cash Flow Less CapEx to Interest Expense
-3.33 8.59 8.12 6.47 -2.41 8.28 9.48 6.63 0.01 9.12 7.01
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.99 0.98 0.98 0.99 0.96 0.94 0.93 0.95 0.94 0.93 0.94
Accounts Receivable Turnover
8.04 7.46 7.80 9.51 8.20 7.49 7.64 9.10 7.97 7.31 7.41
Inventory Turnover
4.76 5.05 5.27 5.16 4.83 4.94 5.24 5.24 4.89 4.97 5.31
Fixed Asset Turnover
8.56 8.25 7.78 7.25 6.91 6.65 6.41 6.15 6.08 6.08 6.12
Accounts Payable Turnover
4.88 4.80 4.79 5.21 4.76 4.66 4.78 5.23 4.77 4.62 4.80
Days Sales Outstanding (DSO)
45.42 48.91 46.82 38.37 44.54 48.71 47.80 40.10 45.79 49.97 49.23
Days Inventory Outstanding (DIO)
76.65 72.22 69.29 70.80 75.59 73.82 69.69 69.71 74.63 73.48 68.75
Days Payable Outstanding (DPO)
74.87 76.12 76.22 70.04 76.73 78.31 76.37 69.73 76.54 79.08 76.07
Cash Conversion Cycle (CCC)
47.20 45.01 39.90 39.13 43.40 44.22 41.11 40.08 43.87 44.37 41.91
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
14,059 13,891 14,058 13,729 14,707 14,817 15,699 15,262 15,914 15,633 15,508
Invested Capital Turnover
1.63 1.66 1.69 1.71 1.60 1.61 1.56 1.63 1.56 1.60 1.60
Increase / (Decrease) in Invested Capital
-32 68 845 439 648 927 1,642 1,533 1,207 816 -192
Enterprise Value (EV)
99,081 85,654 106,181 95,290 98,350 96,463 97,608 90,989 90,907 96,700 90,007
Market Capitalization
88,526 75,515 96,279 85,612 87,774 86,046 86,334 80,325 79,424 84,922 78,476
Book Value per Share
$13.88 $14.80 $16.48 $16.09 $16.43 $17.56 $17.75 $18.55 $17.88 $15.63 $16.38
Tangible Book Value per Share
($31.27) ($29.77) ($28.38) ($28.04) ($28.13) ($27.73) ($27.41) ($29.87) ($30.10) ($32.32) ($31.90)
Total Capital
14,239 14,091 14,296 13,940 14,907 15,087 15,941 15,470 16,131 15,927 15,772
Total Debt
10,735 10,339 10,140 9,888 10,776 10,686 11,516 10,871 11,700 12,072 11,795
Total Long-Term Debt
8,130 8,131 8,175 8,177 7,827 7,829 9,318 9,321 9,323 8,327 7,943
Net Debt
10,555 10,139 9,902 9,678 10,577 10,417 11,274 10,664 11,483 11,779 11,531
Capital Expenditures (CapEx)
284 251 235 298 189 182 196 220 138 108 129
Debt-free, Cash-free Net Working Capital (DFCFNWC)
784 592 482 93 913 817 629 431 1,125 824 767
Debt-free Net Working Capital (DFNWC)
964 792 721 304 1,112 1,086 870 638 1,342 1,117 1,031
Net Working Capital (NWC)
-1,641 -1,416 -1,244 -1,408 -1,837 -1,771 -1,327 -913 -1,035 -2,628 -2,822
Net Nonoperating Expense (NNE)
70 59 87 64 80 88 92 104 98 90 108
Net Nonoperating Obligations (NNO)
10,555 10,139 9,902 9,678 10,577 10,417 11,274 10,664 11,483 11,779 11,531
Total Depreciation and Amortization (D&A)
173 176 169 181 190 191 190 210 218 221 216
Debt-free, Cash-free Net Working Capital to Revenue
3.41% 2.57% 2.09% 0.40% 3.96% 3.54% 2.70% 1.83% 4.70% 3.37% 3.08%
Debt-free Net Working Capital to Revenue
4.20% 3.44% 3.13% 1.31% 4.83% 4.71% 3.74% 2.71% 5.61% 4.58% 4.14%
Net Working Capital to Revenue
-7.14% -6.15% -5.40% -6.10% -7.97% -7.67% -5.70% -3.87% -4.32% -10.77% -11.33%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.00 $3.55 $3.22 $1.91 $2.02 $3.04 $3.38 $1.93 $2.18 $3.46 $3.41
Adjusted Weighted Average Basic Shares Outstanding
252.50M 251M 250.60M 251M 249.40M 248.40M 246.20M 247.60M 245.70M 243.90M 240.70M
Adjusted Diluted Earnings per Share
$1.97 $3.50 $3.18 $1.90 $2.00 $3.00 $3.35 $1.91 $2.15 $3.43 $3.38
Adjusted Weighted Average Diluted Shares Outstanding
255.80M 254.20M 253.90M 254.10M 252.50M 251.30M 249M 250.40M 248.10M 246M 242.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
253.55M 252.26M 251.85M 251.36M 250.60M 249.33M 247.89M 247.77M 246.64M 242.76M 241.59M
Normalized Net Operating Profit after Tax (NOPAT)
576 949 893 545 584 843 925 581 633 933 929
Normalized NOPAT Margin
10.72% 15.13% 14.49% 10.28% 11.00% 13.34% 14.55% 10.38% 11.17% 13.75% 13.54%
Pre Tax Income Margin
11.92% 18.71% 16.60% 11.62% 12.31% 15.61% 16.68% 11.42% 12.00% 16.39% 15.50%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
7.15 11.58 10.87 7.24 7.26 9.75 10.03 5.83 6.14 9.15 8.59
NOPAT to Interest Expense
5.59 8.56 8.64 5.53 5.62 7.50 7.89 4.42 4.81 6.87 6.67
EBIT Less CapEx to Interest Expense
4.40 9.32 8.59 4.21 5.44 8.13 8.35 4.16 5.09 8.35 7.67
NOPAT Less CapEx to Interest Expense
2.83 6.30 6.36 2.51 3.80 5.88 6.22 2.75 3.76 6.07 5.74
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
26.88% 26.74% 27.33% 26.98% 27.66% 29.89% 30.09% 30.75% 30.26% 29.24% 29.32%
Augmented Payout Ratio
96.23% 101.40% 102.19% 91.83% 85.31% 93.90% 101.97% 95.24% 102.60% 126.82% 121.81%

Financials Breakdown Chart

Key Financial Trends

Sherwin-Williams (NYSE:SHW) is showing a meaningful earnings and cash-flow rebound in 2026, although leverage and liquidity remain important risks. Based on the supplied quarterly data, the company’s recent improvement follows softer operating performance during parts of 2025.

In Q2 2026, revenue increased 7.5% year over year to $6.79 billion. Gross profit rose 7.0% to $3.34 billion, while operating income grew 11.9% to $1.23 billion. The operating margin improved to approximately 18.1%, compared with 17.4% in Q2 2025. Net income increased 11.8% to $843.6 million, and diluted earnings per share rose 14.3% to $3.43.

Cash generation also strengthened. Q2 operating cash flow was $1.35 billion, up from $1.11 billion a year earlier, while capital expenditures declined to $108.4 million from $181.5 million. This produced estimated free cash flow of approximately $1.24 billion for the quarter. However, the company used substantially more than that amount for share repurchases and dividends, resulting in a $1.06 billion financing cash outflow.

The balance sheet has expanded since late 2022, with total assets rising from $22.6 billion to $26.95 billion at June 30, 2026. Total equity increased from $3.10 billion to $3.85 billion over the same period. Nevertheless, the company’s current liabilities of $9.63 billion were considerably higher than current assets of $6.999 billion, resulting in a current ratio below 1.0. Total short- and long-term debt stood at approximately $12.07 billion.

  • Revenue growth has accelerated: Q2 2026 revenue rose 7.5% year over year, following 6.8% growth in Q1 2026 and 5.6% growth in Q4 2025.
  • Profitability is improving: Q2 operating income increased nearly 12%, outpacing revenue growth and lifting the operating margin to about 18.1%.
  • EPS growth exceeded net-income growth: Diluted EPS rose to $3.43 from $3.00 in Q2 2025, helped by a lower diluted share count of 246.0 million versus 251.3 million.
  • Operating cash flow is strong: Q2 2026 operating cash flow increased 21% year over year to $1.35 billion, and estimated free cash flow improved to roughly $1.24 billion.
  • Capital spending moderated: Q2 capital expenditures fell approximately 40% year over year, allowing more operating cash to convert into free cash flow.
  • Shareholder returns remain substantial: Sherwin-Williams repurchased approximately $1.26 billion of stock and paid $197.5 million in dividends during Q2 2026, supporting per-share results and maintaining dividend distributions.
  • Working-capital trends are volatile: Q1 2026 operating cash flow was only $139.1 million because of a $767 million use of operating working capital, but Q2 produced a much stronger $1.35 billion inflow. Investors should assess cash flow over several quarters rather than rely on one period.
  • Recent growth follows a mixed multi-year pattern: Quarterly revenue and earnings generally improved from 2023 into 2024, softened in portions of 2025, and rebounded in the first half of 2026. Sustaining the latest growth rate will be important to the investment case.
  • Liquidity is tight on a conventional basis: June 2026 current assets of $7.00 billion were below current liabilities of $9.63 billion, while cash and equivalents were only $293.5 million.
  • Debt remains elevated: Total debt was approximately $12.07 billion at June 30, 2026, and Q2 cash interest paid was $115.8 million. Higher interest costs can limit financial flexibility if operating conditions weaken.
  • Buybacks are aggressive relative to cash on hand: The $1.26 billion Q2 repurchase was more than four times the company’s $293.5 million cash balance at quarter end, increasing reliance on ongoing cash generation and capital-market access.
  • Intangible assets represent a significant portion of the balance sheet: Goodwill and intangible assets totaled approximately $11.83 billion, or about 44% of total assets. This increases exposure to potential impairment charges if acquired businesses underperform.
11/17/26 08:42 PM ETAI Generated. May Contain Errors.

Sherwin-Williams Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Sherwin-Williams' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Sherwin-Williams' net income appears to be on an upward trend, with a most recent value of $2.57 billion in 2025, rising from $1.05 billion in 2015. The previous period was $2.68 billion in 2024. Check out Sherwin-Williams' forecast to explore projected trends and price targets.

Sherwin-Williams' total operating income in 2025 was $3.81 billion, based on the following breakdown:
  • Total Gross Profit: $11.52 billion
  • Total Operating Expenses: $7.70 billion

Over the last 10 years, Sherwin-Williams' total revenue changed from $11.34 billion in 2015 to $23.57 billion in 2025, a change of 107.9%.

In the past 11 quarters, Sherwin-Williams' cash and equivalents has ranged from $179.90 million in Q1 2024 to $293.50 million in Q2 2026, and is currently $264.20 million as of their latest financial filing in Q3 2026.

Sherwin-Williams had total debt of $10.87 billion at the end of 2025, a 9.9% increase from 2024, and a 457.5% increase since 2015.

Over the last 10 years, Sherwin-Williams' book value per share changed from 9.32 in 2015 to 18.55 in 2025, a change of 99.0%.



Financial statements for NYSE:SHW last updated on 10/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners